The review summarizes relevant research focused on prevalence and natural history of gender nonconforming/transgender youth, and outcomes of currently recommended clinical practice guidelines. This review identifies gaps in knowledge, and provides recommendations foci for future research.
INTRODUCTION
Although significant advances in the last 2 decades have been made in the understanding of transgender individuals and approach to care, many questions remain unanswered. In June of 2014, a group of endocrinologists and other medical professionals experienced in the care of transgender individuals convened at the Endocrine Society Annual Meeting to form TransNet. TransNet is an international collaboration aimed at studying the medical and behavioral outcomes of psychological, hormonal, and surgical interventions currently utilized to alleviate gender dysphoria, as well as the epidemiology and cause of the transgender phenomenon. The focus of this manuscript is to summarize the report of the TransNet working group on Gender Nonconforming/Transgender Youth presented at the National Institute of Child Health and Human Development in May of 2015. This working group was charged with summarizing relevant existing research focused on prevalence, natural history, and outcomes of currently recommended clinical practice guidelines, identifying gaps in knowledge, as well as limitations of and barriers to optimal care. In addition, the group focused on current knowledge of biologic factors that influence the development of gender identity. Finally, this summary concludes with recommendations foci for future investigations in this rapidly expanding field.
BACKGROUND
Individuals with gender behaviors, expression, and identities that depart from the cultural norms and expectations implied by their assigned sex at birth have been labeled 'gender nonconforming', 'gender expansive', or most commonly, 'transgender'. Many, but not all, gender nonconforming or transgender individuals experience gender dysphoria, the ongoing distress that arises from the incongruity of assigned sex at birth and internal experience of gender. Gender dysphoria is described in the Diagnostic and Statistical Manual of Mental Disorders, version 5 (DSM-5), and replaces the previous clinical entity, 'Gender Identity Disorder [1] '.
An increasing number of preadolescents and adolescents identifying as 'gender nonconforming', 'gender expansive', or 'transgender' are seeking medical services to diminish gender dysphoria, and enable the development of physical characteristics consistent with their experienced gender. Concomitantly, the number of dedicated transgender youth clinics has been expanding in pediatric hospitals and institutions around the USA [2,3 && ,4 && ,5,6], whereas the average age at referral has dropped over the last decade [2, 7] .
As transgender stories have become increasingly visible in the mainstream media, as well as an increase in access to the transgender community via the Internet, conversations about gender identity have been changing. Although data describing prepubertal gender nonconforming youth indicate that most do not persist as transgender adolescents or adults, some studies have yielded tentative predictors of persistence. What is missing is information that can be used clinically for predicting individual psychosexual development pathways [8] [9] [10] [11] .
The onset of puberty in transgender youths is often accompanied by specific anatomic dysphoria, that is, distress evoked by the incongruence between the experienced gender identity and the developing secondary sex characteristics. In 2009, the Endocrine Society published Guidelines for the Care of Transsexual Individuals that included recommendations for the treatment of gender dysphoric youth. One important recommendation is the use of gonadotropin hormone releasing hormone analogues to suspend the endogenous puberty of gender dysphoric youth in the early stages of puberty (Tanner 2-3) with the addition of cross-sex hormones at about the age of 16 to induce masculine or feminine features that more closely align with the young person's internal experience of gender. Surgical intervention to improve gender dysphoria is recommended after the age of majority [12] . These recommendations are based on limited longitudinal studies demonstrating that those individuals identified as gender dysphoric in early or middle childhood who continue to meet the mental health criteria for a diagnosis of gender dysphoria at early puberty are likely to identify as transgender adults.
Although recent reports from the Netherlands have shown that gender dysphoria may indeed be ameliorated by a gender-affirming model of care, including puberty suppression, cross-sex hormones, and gender confirming surgery, currently available data are relatively limited and many questions remain unanswered [13,14 && ,15 & ]. Well outlined in the extant literature are data that consistently reveal transgender youth are at increased risk for depression, suicide, and other adverse outcomes, including illicit drug use and HIV infection [16, 17, 18 && ]. The goal of ongoing and future research is to gain a better understanding of gender non-conformity and transgender experiences from early childhood through early adulthood. For the youngest cohort of gender nonconforming children, the impact of early social transition on physical health and social functioning has not been determined. For older youth, further specific inquiry is necessary to determine if puberty suppression in early pubertal gender dysphoric
KEY POINTS
Increasing numbers of gender nonconforming youth are presenting for care.
Transgender youth are at high risk for poor medical and psychosocial outcomes.
Longitudinal data examining the impact of early social transition and medical interventions are sparse.
Biomedical data are beginning to change the trajectory of scientific investigation.
Extensive research is needed to improve understanding of gender dysphoria, and transgender experience, particularly among youth. youth, followed by cross-sex hormones, leads to improved quality of life and a decrease in negative mental health outcomes. In addition, for gender dysphoric youth presenting in late puberty or after completion of puberty, it will also be important to determine the impact of phenotypic transition on quality of life and mental health outcomes. Also useful would be studies examining the characteristics of those youth who choose to not pursue cross-sex hormones, or discontinue their use after starting.
Biologic underpinnings of gender
Gender identity development is thought to reflect a complex interplay of biologic, environmental, and cultural factors. Studies that shed light on the biologic underpinnings of gender identity may underscore the concept that, much like sexual orientation, gender identity is not a choice, and may thus promote further understanding and acceptance of transgender individuals. With respect to evidence supporting biologic underpinnings of gender identity, data are derived primarily from three biomedical disciplines: endocrine, genetic, and neuroanatomical, recently reviewed [19 && ,20 && ].
Androgens and gender identity
Although the majority of transgender individuals do not have a disorder of sex development, studies of persons with DSDs have helped inform our understanding of gender identity. Such studies have primarily explored the role of prenatal and postnatal androgens in gender identity development.
Although a detailed analysis is beyond the scope of this manuscript, insights about the potential role of androgens have been derived primarily from infants assigned female who had diverse hormonal DSDs (e.g., 46,XX individuals with increased androgen exposure and 46,XY individuals with decreased androgen exposure/activity) and nonhormonal DSDs (e.g., 46 ,XY individuals with cloacal exstrophy). When raised female, the majority of these individuals reported a female sex identity in adulthood, but the prevalence of transmasculine identity was significantly greater than expected in the general population [21, 22] . Thus, studies conducted with people with DSDs suggest a limited, but significant role of prenatal and potentially postnatal androgens in gender identity development.
Genetic contribution to gender dysphoria
Numerous studies have suggested a role of genetics in gender identity development. A review of earlier case reports on twin pairs yielded a 39.1% concordance rate of transgender identities in monozygotic twin pairs versus 0% in dizygotic twin pairs, which implicates genetic factors in the development of gender identity [23] . Studies aimed at identification of individual candidate genes have been inconsistent.
Neuroanatomical considerations
A review of the MRI structural brain studies using voxel based morphometry, cortical thickness, and diffusion tensor imaging, shows that the brain phenotype of adult transgender individuals might consist of a mixture of feminine, masculine, and defeminized traits in transgender men and feminine, masculine, and demasculinized traits in transgender women [24] [25] [26] [27] [28] .
During the last couple of years the first study of structural connectivity using graph theory was reported. Connectivity has also been approached using resting-state functional MRI(fMRI) [29] . Both structural and connectivity studies provide evidence for phenotypes for transgender women and men. The fMRI studies have been focused on sexually dimorphic traits like visuospatial abilities (mental rotation) [30, 31] and verbal fluency [32] . In addition, PET studies have addressed hypothalamic responses to putative pheromones that act in a sexually dimorphic manner [33] .
Although fMRI and PET studies show that gender incongruent persons have patterns of activation that differ from their natal sex, more integrative work and future research on the cause of gender incongruence and gender dysphoria are needed.
One recent neuroimaging study showed that gray matter volumes of adolescents with gender dysphoria are, on a whole brain level, in line with their natal sex, but when analyses are done in regions of interest, there is some indication for sex atypical differentiation [34 & ]. There is only one fMRI study exploring puberty suppression and executive functions [35 & ]. Brain studies are potentially important in the child and adolescent age group to clarify the cause of gender dysphoria and to examine the effects on the brain of puberty blockers and cross-sex hormone treatment.
Prevalence of gender nonconforming children and adolescents
There is no consensus on the prevalence of gender nonconformity among children and adolescents, and conducting studies in this area is fraught with methodological challenges ranging from recruitment and reporting biases to difficulties in measurement given the fluidity and nonbinary nature of gender expression and identity. Among Dutch children assessed on the Child Behavior Checklist, 2.5-5% of parents responded positively to a question related to their child 'behaving like the other sex' and 1.4-2% responded positively to their child identifying as the other sex. Among Dutch adolescents, 1.1-3.1% responded positively to behaving like the other sex, and 0.2-0.4% identifying as the other sex [36, 37] . Among children in the USA assessed with the Child Behavior Checklist, between 1.3 and 5.0% of parents responded positively to queries regarding their children 'wishing to be of the opposite sex' and between 0.9 and 12.9% responded positively to the query regarding 'behaving like the opposite sex' [36] . The sex ratio of gender dysphoric youth evaluated in Toronto and Amsterdam prior to 2006 indicated that there were significantly higher numbers of individuals assigned male at birth than those assigned female at birth. However, from 2006 to 2013, the ratio in both clinics favored individuals assigned female at birth [38] . Clinicians from gender clinics in the USA report a ratio closer to 1 : 1, with a growing number of assigned females at birth [4 && ,39].
Developmental pathways
Two areas of interest and importance to both families and caregivers is the percentage of gender dysphoric children who go on to have gender dysphoria and/or transgender identities in adolescence and adulthood ('persisters'), and what the predictors are of this developmental trajectory. The earliest studies published prior to 1987 identify a very small number of 'persisters' ranging from 2 to 9% [40, 41] . The subjects in these reports were small in number, assigned male at birth, with unclear diagnoses in terms of DSM criteria of gender identity disorder (DSM IV-TR) or gender dysphoria [42] . In more recent studies, persistence rates range from 12 to 39%, but also include children who are subthreshold for DSM diagnoses [8, 43, 44] . All of the existing studies include both gender nonconforming and gender dsyphoric youth, drawn from clinics with different approaches to care, and using differing follow-up intervals. Predictors associated with the persistence of gender dysphoria in the Netherlands include intensity of gender dysphoria in childhood, older age of presentation to the clinic, female assignment at birth, and social transition to the asserted gender in childhood [8] [9] [10] [11] 43] . Clinicians in the USA and the Netherlands report that increasing numbers of children are choosing to socially transition prior to the onset of puberty [10] . In a qualitative study from the Netherlands, 14 youth with persistent gender dysphoria, and 11 youth whose gender dysphoria dissipated were interviewed to further understand the differences in their experiences of gender over time. The age that seemed to be crucial for the developmental trajectory of persistent gender dsyphoria or transgender identity was between 10 and 13 years. Reported factors that affected persisters and desisters differentially were the changes in their social environment, body changes associated with puberty and the experience of falling in love or experiencing sexual attraction [11] .
Behavioral and emotional problems
The behavioral and emotional problems of children with gender dysphoria have been fairly consistent in the extant literature. The data come from sites outside of the USA: Canada, the Netherlands, UK, and Germany, again highlighting the need for studies conducted within the USA. Children with gender variance show both increased internalizing and externalizing behavioral and emotional problems compared with nonreferred controls [44, 45] . Additionally, studies have shown that adolescents with gender dysphoria have even greater emotional and behavioral problems than gender variant children [46, 47] . In 2011, deVries et al. reported on 70 transgender youth eligible (by conservative criteria) for medical intervention at the Amsterdam Gender Identity Clinic of The VU University Medical Center. In total, 44% of the sample scored in the clinical range on the Child Behavior Checklist total problem scale (compared with 8-9% Dutch adolescent norm), and 29.6% scored in the clinical range on the Internalizing Scale of the Youth Self-Report (also compared with 8-9% Dutch adolescent norm) [48] . In another Dutch study on 105 adolescents it was found that, according to DSM-IV criteria, anxiety disorders occurred in 21%, mood disorders in 12.4%, and disruptive disorders in 11.4% [49] . A 2012 report of transgender youth presenting to the Gender Management Service at Boston Children's Hospital showed high prevalence of psychiatric morbidities, including depression (58.1%) and anxiety (16.3%) [38] . In 2014, a report from Vancouver, British Columbia, Canada, reported similar psychiatric morbidity among 84 transgender youth, including mood disorders (35%), anxiety disorder (25%), suicide attempt (12%), and psychiatric hospitalizations (12%) [3 && ]. In a study of 101 youth in Los Angeles with gender dysphoria, 35% of participants had depression scores in the clinical range, 51% reported ever thinking about suicide, and 30% had attempted suicide at least once in their lives [4 && ].
Evaluation of the outcome of puberty suppression followed by cross-sex hormone administration has only taken place in cohorts of youth undergoing treatment in the Netherlands. Of the first 70 youth presenting to the clinic in childhood, 55 had, at the time of the study, 'completed' the Dutch treatment model (beginning puberty suppression at the age of 12 years, initiating cross-sex hormones at 16 years, and performing gender confirmation surgeries after age 18 years) and agreed to participate. After puberty suppression with GnRH analogues, scores on the Child Behavior Checklist were significantly reduced. One year after surgery, gender dysphoria was significantly decreased, body satisfaction with primary sexual characteristics significantly improved, and subjective well-being was similar or better than in age-comparable young adults from the general Dutch population [14 && ]. Standardized quantitative measures and systematic qualitative studies designed to collect information about children's experience of gender and gender dysphoria would help us understand the cognitive and emotional processes involved.
Autism spectrum disorders and gender variance
The prevalence of autism spectrum disorder was found to be 10 times higher in the population of Dutch children with gender dysphoria, who were referred to a gender identity clinic, than in a population of typical children [50] . Prevalence statistics from a referral population may not be generalized to the larger population. Because it may be more difficult to diagnose and counsel children and adolescents who have gender dysphoria and autism, future studies should examine the relationship between these two conditions in more detail.
Existing tools to measure gender
Critical to understanding optimal timing and outcomes of intervention for children and youth is the development of accurate tools to measure gender dysphoria. Currently, there are four scales used to evaluate gender identity/dysphoria. For adolescents there is the Utrecht Gender Dysphoria Scale and the Gender Identity/Gender Dysphoria Questionnaire for Adolescents and Adults [51] . The Utrecht Gender Dysphoria Scale is a 12-item tool that assesses aspects of female and male experience that may be problematic for gender dysphoric youth. Higher scores on this scale indicate higher or more intense levels of gender dysphoria. There are two different sets of questions, one for assigned girls and one for assigned boys. The questions are different, and therefore not comparable. This limits understanding of the differences between transmasculine and transfeminine experiences of gender dysphoria. Additionally, the elements of the scale are such that comparisons of gender dysphoria in pre and posttreatment participants necessitate administration of the opposite questions in the post-treatment evaluation. Finally, the questions are very gender binary in nature, with no adequate mechanism to capture those youth who have nonbinary gender identities. The Gender Identity/Gender Dysphoria Questionnaire for Adolescents and Adults is not appropriate for younger adolescents, and is also gender binary in the nature of the inquiries. To identify gender identity and gender dysphoria in children there is the Gender Identity Questionnaire of Childhood [52] [53] [54] [55] and the Gender Identity Interview for Children [49] . The parent-administered GICQ assesses both gender-typical behaviors and gender identity in combination rather than separately. However, the Gender Identity Questionnaire is an instrument that does examine the child's own gender experience. The development of culturally relevant tools that reflect the child/adolescent's experience of gender identity, as well as measures of gender dysphoria that might change over time are absolutely necessary to understand the impact of interventions.
Gaps in knowledge
Virtually all of the outcome data in gender nonconforming children, peripubertal, and adolescent transgender youth have been carried out in Europe and Canada [13,14 && ,15 & ,56] . There are no long-term outcome data for either prepubertal or adolescent transgender youth originating from the USA. Recently, a four-site study in the USA designed to examine the impact of early treatment in transgender youth was funded by the National Institute of Health and is about to begin.
Although the work in the Netherlands has been critical to the field of transgender youth care, the results are limited for several reasons. Primarily, gender dysphoric youth in the Netherlands may not reflect the ethnic or cultural diversity of transgender youth in the USA and elsewhere around the world. In addition, the social context of growing up as a gender dysphoric child in the Netherlands, including outcomes related to the use of pubertal blockers and cross-sex hormones may be quite different than in other parts of the world. Transgender and gender nonconforming youth are seen in one specific gender identity clinic that is the primary resource for the majority of gender dysphoric children and adolescents in the Netherlands. Additionally, because of the constraints of the current health system and resulting lack of access to adequate and timely care in the USA, there is poor consistency to medical practice models around the country.
CONCLUSION
Significant gaps in knowledge exist in nearly all aspects of gender variance, gender dysphoria and transgender experiences of children, adolescents, and young adults. This working group has divided the research priorities and recommendations into three distinct cohorts; prepubertal gender nonconforming/variant children, early pubertal youth, and late pubertal/postpubertal youth. 
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